KLOW80 Peptide Blend Research Profile
KLOW80 is a compound lyophilized peptide mixture consisting of GHK-Cu, , TB-500 and KPV with fixed proportion. Each independent peptide raw material adopts high-purity synthetic raw material, tested by HPLC to guarantee consistent batch quality. This multi-peptide combination reagent is developed to support scientific researchers to explore the synergistic biological signal activities of multiple bioactive peptides under laboratory controlled conditions. All content below only describes research directions based on published academic literatures, and does not constitute any functional guarantee for practical application.
GHK-Cu, copper glycyl histidyl lysine tripeptide complex, is the core component of this formula. A large number of in-vitro cell experiments have been carried out on this peptide globally. Relevant laboratory observations indicate that this peptide participates in the regulation of fibroblast biological behaviors. Researchers use GHK-Cu to carry out experimental exploration on extracellular matrix metabolism, studying its influence on the synthesis pathway of collagen and related matrix proteins in cell culture models. Meanwhile, related research focuses on its antioxidant characteristics within cellular microenvironment, investigating its regulating effect on reactive oxygen species balance. Besides, multiple research projects take this peptide as experimental object to analyze its influence on cell adhesion and cell migration signal transduction, widely applied in dermatology-related basic cell research, biomaterial construction and tissue microenvironment simulation experiments.
, stable pentadecapeptide, is widely selected as experimental material in tissue-related basic research. In existing laboratory models, scholars focus on exploring its regulatory role on endothelial cell activity. Research teams utilize to observe changes of angiogenesis-related signal factors in cell models, exploring its influence on endothelial cell migration and tubular structure formation. Besides, experimental research also covers its regulatory effect on cell survival signals, exploring the balance mechanism between cell apoptosis and cell proliferation in simulated stress environment. Many in-vitro and preclinical experimental systems adopt this peptide to study soft tissue cell signal network, providing reference data for exploring biological behaviors of connective tissue cells under external stimulation.
TB-500 is the active amino acid fragment derived from Thymosin Beta 4, which is a common experimental reagent for cytoskeleton research. Core research directions center on actin binding characteristics. Under laboratory conditions, researchers study how TB-500 regulates cytoskeleton assembly and disassembly, further affecting directional movement of multiple types of somatic cells. Relevant cell scratch experiments and tissue simulation models are used to record cell mobility variation after adding this peptide. Moreover, scholars also carry out long-term research on its influence on intercellular signal transmission, exploring its potential correlation with tissue cell reconstruction process under mechanical stimulation, which is of great value for musculoskeletal cell basic research and biological wound model research.
KPV tripeptide (Lys-Pro-Val) acts as the inflammation signal regulating component in KLOW80 formula, distinguishing this four-peptide blend from triple peptide combinations. Academic research mainly concentrates on its impact on NF-κB signal pathway. In immune cell culture experiments, researchers observe that KPV can adjust the transcription level of multiple inflammation-related cytokines, regulating the excessive activation of inflammatory signal cascade. Multiple laboratory models are built to explore its immunomodulatory characteristics, studying the balance between pro-inflammatory and anti-inflammatory factors in local microenvironment. This peptide is often used in mucosal cell models, epidermal cell culture systems and inflammatory cell co-culture experiments for exploring the regulation mechanism of local cell inflammatory response.
The core research value of KLOW80 lies in the simultaneous existence of four peptides with different action pathways in a single reagent. Single peptide research can only observe the activity of individual signal pathway, while KLOW80 provides convenient experimental conditions for exploring peptide synergistic effects. Researchers do not need to purchase four kinds of lyophilized powder separately, complete independent reconstitution and proportional mixing, effectively reduce manual operation errors in experiment preparation, save laboratory research cost and experimental time. The matched ratio of each peptide in the formula is summarized and optimized according to a large number of multi-peptide co-culture experimental data, which can directly support repeated parallel experiments and comparative group setting.
The applicable research fields of KLOW80 cover multiple basic biology directions. First, cell signal transduction research: researchers can take this blend as experimental object to analyze the interaction between collagen metabolism signal, angiogenesis signal, cytoskeleton regulation signal and inflammatory immune signal. Second, biomaterial research: it can be added into hydrogel, biological scaffold material system to develop composite biological experimental materials, exploring the influence of bioactive peptides on material surface cell adhesion characteristics. Third, skin cell basic research: adopt epidermal cell, fibroblast co-culture model to explore multi-peptide’s comprehensive influence on skin cell microenvironment. Fourth, soft tissue biological research: establish in-vitro connective tissue simulation model to record cell activity changes under combined peptide intervention. Fifth, immune microenvironment research: construct inflammatory cell culture system to study how multiple peptides jointly adjust local cytokine network.
Product physical form is blue-violet lyophilized powder, formed by vacuum freeze-drying technology. Freeze-drying process can well maintain the stability of peptide molecular structure, slow down molecular degradation during storage. Strict low-temperature sealed storage condition is recommended. After reconstitution with sterile solvent, it can be added into cell culture medium for in-vitro cell experiments. All reconstitution operations need to be completed under sterile laboratory environment to avoid microbial contamination interfering experimental data. Each batch of products comes with complete COA test report, including molecular weight identification, purity detection, moisture content and endotoxin test indicators, to meet the quality control requirements of formal research laboratories.
Compared with self-mixed multi-peptide samples, KLOW80 has obvious advantages in component uniformity. Industrial standardized production ensures each vial maintains stable peptide proportion. Manual mixing in laboratories easily leads to proportion deviation, affecting repeatability of experimental data. This pre-mixed compound peptide reagent is suitable for long-term continuous research projects, batch repeated verification and multi-group comparative experiments. It has been selected by many biological research laboratories, cell research institutions and peptide formulation development teams as conventional experimental raw material.
Researchers can design diversified experimental schemes according to their own research topics. It can be set as experimental group with gradient concentration, compared with single peptide control group, blank solvent control group, to distinguish independent activity and synergistic activity of composite peptides. Relevant experimental data obtained can be used for academic paper research, internal laboratory project reports, new biomaterial formula exploration and peptide related preliminary mechanism research.
Important Compliance Disclaimer (Must be displayed prominently)
THIS PRODUCT IS FOR LABORATORY SCIENTIFIC RESEARCH USE ONLY. NOT FOR HUMAN INGESTION, TOPICAL APPLICATION, ANIMAL TREATMENT, CLINICAL USE OR COSMETIC PRODUCTION. All statements described above are only summaries of public academic research directions, and cannot be regarded as functional evaluation or application guidance. All experimental operations must be carried out by qualified professional researchers, following biosafety operation specifications.